Yüklüyor......

A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

Although initial rituximab-containing chemotherapies achieve high response rates, indolent B-cell non-Hodgkin lymphoma (B-NHL), such as follicular lymphoma (FL), is still incurable. Therefore, new effective agents with novel mechanisms are anticipated. In this multicentre phase II study, patients wi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Haematol
Asıl Yazarlar: Ogura, Michinori, Ando, Kiyoshi, Suzuki, Tatsuya, Ishizawa, Kenichi, Oh, Sung Yong, Itoh, Kuniaki, Yamamoto, Kazuhito, Au, Wing Yan, Tien, Hwei-Fang, Matsuno, Yoshihiro, Terauchi, Takashi, Yamamoto, Keiko, Mori, Masahiko, Tanaka, Yoshinobu, Shimamoto, Takashi, Tobinai, Kensei, Kim, Won Seog
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BlackWell Publishing Ltd 2014
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282031/
https://ncbi.nlm.nih.gov/pubmed/24617454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12819
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!